This is not a complete list of risks or precautions-always review the full safety information provided with your prescription and discuss concerns with your healthcare provider
Likelihood of Accepting Treatment of GLP-1 vs Existing MOUD Options Does offering semaglutide or tirzepatide as one of the options for AUD or OUD treatment increase the likelihood of patients accepting treatment vs only offering existing therapies like naltrexone, buprenorphine, or methadone
And then the last thing Ill note, too, is theres a lot of serious, like, gastrointestinal side effects, and that kind of harkens back to the, you know, people quitting after two years, so
Statistical significance was determined by a two-sided unpaired t-test compared to non-cancer samples ( a , b , c ), or untreated cells ( f )
Visual indicators to watch Color changes suggest oxidation or other chemical degradation